AbbVie Receives NDA for Atogepant, Aims to Stop Migraines in Their Tracks

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Mar 31, 2021 at 11:12 PM.

  1. #1 cafead, Mar 31, 2021 at 11:12 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via There was new hope on Tuesday for millions of migraine sufferers as AbbVie announced the U.S. Food and Drug Administration (FDA) acceptance of its New Drug Application (NDA) for atogepant, which aims to prevent the often debilitating condition.

    article source
     
    Quote

  2. #2 anonymous, Jul 31, 2021 at 8:36 PM
    anonymous

    anonymous Guest

    Shit division with a bunch of bitches!
     
    Quote
Reply to Thread